CompletedNot Applicable

A Registry Study on Primary/idiopathic Triglyceride Deposit Cardiomyovasculopathy

Japan193 participantsStarted 2022-03-31

Plain-language summary

The objective of this study is to construct a registry; in order to understand the onset status of triglyceride deposit cardiomyovasculopathy (TGCV) in Japan with patients' background and natural history of the disease, and to explore disease-specific prognostic factors.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients who have been conﬁrmed as TGCV based on the diagnostic criteria for TGCV Exclusion Criteria: * The patients who refused to participate in the study by opt-out

What they're measuring

The period between the date of TGCV diagnosis and the date of death due to any cause

Timeframe: 10 years

Trial details

NCT IDNCT05345223

SponsorTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-31

View on ClinicalTrials.gov More Triglyceride Deposit Cardiomyovasculopathy trials